Safety assessment of niacin in the US Food and Drug Administration's mini-sentinel system.
Joshua J GagneMonika HoustounMarsha E ReichmanChristian HamppJames H MarshallSengwee TohPublished in: Pharmacoepidemiology and drug safety (2017)
We did not observe evidence for an association between extended-release niacin versus fenofibrate and rates of major gastrointestinal bleeding or intracranial hemorrhage.